Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Efficient induction of immune tolerance to coagulation factor IX following direct intramuscular gene transfer.

Efficient induction of immune tolerance to coagulation factor IX following direct intramuscular gene transfer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Efficient induction of immune tolerance to coagulation factor IX following direct intramuscular gene transfer. Abstract Text:

    e f cohnE F Cohn,j zhuoJ Zhuo,m e kellyM E Kelly,h j chaoH J Chao,

    BACKGROUND: The formation of inhibitory anti-factor IX (anti-FIX) antibodies is a major complication of FIX protein replacement-based treatment for hemophilia B. It is difficult to treat patients with anti-FIX antibodies. Gene therapy is emerging as a potentially effective treatment for hemophilia. Direct i.m. injection of adeno-associated virus (AAV) is a safe and efficient procedure for hemophilia B gene therapy. However, the development of anti-FIX antibodies following i.m. of AAV may impede its application to patients. OBJECTIVE: We aimed to investigate induction of immune tolerance to human FIX (hFIX) by i.m. of AAV1, further validating i.m. of AAV1 for hemophilia B gene therapy. METHODS AND RESULTS: Cohorts of hemostatically normal and hemophilia B mice with diverse genetic and MHC backgrounds received i.m. of AAV-hFIX. Human FIX antigen and anti-hFIX antibodies were examined. I.m. of 1 x 10(11) vector genomes (VG) of AAV2 elicits formation of anti-hFIX antibodies comparable to those by hFIX protein replacement. I.m. of 1 x 10(11) VG of AAV1 results in expression of therapeutic levels of hFIX (up to 950 ng mL(-1), mean = 772 ng mL(-1), SEM +/- 35.7) and hFIX-specific immune tolerance in C57BL/6 mice. CONCLUSIONS: A single i.m. of AAV1 can result in efficient expression of therapeutic levels of hFIX and induction of hFIX tolerance in hemostatically normal and hemophilic B mice. Our results substantiate the prospect of i.m. of AAV1 for hemophilia B gene therapy and FIX tolerance induction.

    Efficient induction of immune tolerance to coagulation factor IX following direct intramuscular gene transfer. Publishing Authors By Initials

    ef cohnEF Cohn,j zhuoJ Zhuo,me kellyME Kelly,hj chaoHJ Chao,

    For similar biological phenomena, cell phenomena, and immunity: immunity: antibody specificity: species specificity research abstracts see: biological phenomena, cell phenomena, and immunity: immunity: antibody specificity: species specificity research

    PUBMED ID PMID:

    MEDLINE DATE:

    Efficient induction of immune tolerance to coagulation factor IX following direct intramuscular gene transfer. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Journal of thrombosis and haemostasis : JTH

    VOLUME: 5

    Page Numbers: 1227-36

    Journal Abbreviation: J. Thromb. Haemost.

    ISSN: 1538-7933

    DAY: 3

    MONTH: Jun

    YEAR: 2007

    Efficient induction of immune tolerance to coagulation factor IX following direct intramuscular gene transfer. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101170508

    Efficient induction of immune tolerance to coagulation factor IX following direct intramuscular gene transfer. Keywords Mesh Terms:

    KEYWORDS: Species Specificity

    MESH TERMS: immunology

    Chemical & Substance for Abstract: Efficient induction of immune tolerance to coagulation factor IX following direct intramuscular gene transfer. Information

    Substance Name: Factor IX

    Registry Number: 9001-28-9

    Grant and Affiliation Information for Efficient induction of immune tolerance to coagulation factor IX following direct intramuscular gene transfer.

    AFFILIATION: Division of Hematology/Oncology, Department of Medicine, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029, USA.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY: United States NHLBI

    GRANT: R01-HL076699

    ACRONYM: HL

    MEDLINETA: J Thromb Haemost

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Efficient induction of immune tolerance to coagulation factor IX following direct intramuscular gene transfer Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News